Capitalizing Life Science Innovations

  NeuBase Logo

Dietrich Stephan, PhD, Founder, Chairman and CEO

NeuBase Therapeutics, Inc. (NASDAQ: NBSE)

"Allele Capital is a world-class group of seasoned professionals who have propelled my company into the public markets thereby allowing us to maximize our impact on patients and create value for our shareholders. I view Allele as an extension of our management team, focused on planning and executing our capital markets strategy. I have been deeply impressed with the time that the team dedicates to us, their deep understanding of the segment, outstanding strategic guidance and also the breadth of their network (including investors, board talent, bankers, analysts, etc.). I have worked with many top scientific researchers, business leaders, and marquee investors in two dozen companies. Allele is best-in-class in each of these areas but fully aligned in creating value for all shareholders. In this business, integrity is paramount as we are dealing with patient lives and shareholder dollars. Each member of the Allele team is of the highest integrity - a precious and rare commodity. I cannot recommend them highly enough."